XTLB: XTL Biopharmaceuticals Company Short-Term Debt
XTL Biopharmaceuticals develops targeted treatments for autoimmune pathologies based on molecular modeling. The safety of clinical tests is guaranteed by strict control over the transportation of biomaterials. A shortage of funds is forcing the company to accumulate new assets to strengthen its position. Short-term loan capital illustrates liquidity dynamics, and 0.00 characterizes this parameter for assessing current liabilities.
Metric breakdowns and analytics for XTL Bio (XTLB)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital XTL Biopharmaceuticals|XTLB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity XTL Biopharmaceuticals|XTLB - Company Total Debt|Debt to Book Capitalization Ratio XTL Biopharmaceuticals Ltd.|XTLB - Company Long-Term Liabilities|Company Current Liabilities XTL Biopharmaceuticals|Quick Liquidity xtlbio.com
- net income and valuation multiples indicators:
Initial company analysis:XTLB - XTL Biopharmaceuticals Ltd.
This metric aggregates all of the issuer's liabilities with a maturity horizon of up to twelve months, reflecting the current liquidity burden and sensitivity to interest rate fluctuations. The dynamics of XTL Biopharmaceuticals (XTLB) short-term loans and borrowings demonstrate a balance between operational financing for expansion in the immunopharmaceuticals sector and the risks of cash flow gaps during the aggressive scaling of the XTL Biopharmaceuticals (XTLB) therapeutic asset portfolio.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|ZBIO (Zenas Corp) - Company Short-Term Indebtedness|IMNM (Immunome, Inc.) - Company Current Liabilities|GOSS: Amount of Current Liabilities|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Debt SEPN|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|Short-Term Debt Aerovate Therapeutics (JBIO)|Company Short-Term Debt Aclaris Therapeutics|kyvernatx.com - Current Liabilities|Company Short-Term Debts TLSA|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts VTYX (Ventyx Bio)|Company Short-Term Debts Theratechnologies, Inc THTX|AVTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ELDN (eledon.com)|Agenus Inc. (AGEN) - Company Short-Term Debt|Company Current Liabilities Climb Bio Inc.|ZURA (Zura Bio) - Company Short-Term Debts|Company Short-Term Debts aTyr Pharmaceuticals|Company Short-Term Debts ADAG|Company Current Liabilities ikenaoncology.com IMA|Company Short-Term Debts STTK (Shattuck Labs)|Equillium Inc (EQ) - Short-Term Debt|CNTB: Company Current Liabilities|IMUX - Company Short-Term Debts|ATRA (atarabio.com) - Company Current Liabilities|IFRX: Amount of Current Liabilities|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|Company Current Liabilities INmune Bio Corporation INMB|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|Company Short-Term Debts kezarlifesciences.com KZR|SABS - Company Short-Term Debt|AKTX: Company Short-Term Debt|enlivex.com (ENLV) - Company Short-Term Debt|QTTB - Short-Term Debt Volume|Company Current Liabilities GOVX|Company Short-Term Indebtedness EDSA (edesabiotech.com)|Company Current Liabilities IBIO (iBio)|Amount of Current Liabilities CARM|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCW Biologics, Inc. - Company Short-Term Debt|Aptevo - Company Short-Term Debts|AIM: Company Short-Term Debt|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc